Ray Dalio Novavax Inc Transaction History

Bridgewater Associates, LP

  • $17.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$36.28 - $75.29 $1.14 Million - $2.36 Million
31,335 Added 779.28%
35,356 $1.82 Million
Q1 2022

May 13, 2022
BUY
$69.73 - $142.9 $110,243 - $225,924
1,581 Added 64.8%
4,021 $296,000
Q4 2021

Feb 14, 2022
BUY
$134.56 - $217.97 $175,331 - $284,014
1,303 Added 114.6%
2,440 $349,000
Q3 2021

Nov 12, 2021
BUY
$177.8 - $270.58 $202,158 - $307,649
1,137 New
1,137 $236,000

Others Institutions Holding NVAX

# of Institutions
292
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email